145 related articles for article (PubMed ID: 30015887)
1. Quercetin‑3‑O‑β‑D‑glucoside decreases the bioavailability of cyclosporin A through regulation of drug metabolizing enzymes, transporters and nuclear receptors in rats.
Yang T; Liu Y; Huang X; Zhang R; Yang C; Zhou J; Zhang Y; Wan J; Shi S
Mol Med Rep; 2018 Sep; 18(3):2599-2612. PubMed ID: 30015887
[TBL] [Abstract][Full Text] [Related]
2. Impact of quercetin‑induced changes in drug‑metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats.
Liu Y; Luo X; Yang C; Yang T; Zhou J; Shi S
Mol Med Rep; 2016 Oct; 14(4):3073-85. PubMed ID: 27510982
[TBL] [Abstract][Full Text] [Related]
3. Inhibition effect of epigallocatechin-3-gallate on the pharmacokinetics of calcineurin inhibitors, tacrolimus, and cyclosporine A, in rats.
Huang X; Zhang R; Yang T; Wei Y; Yang C; Zhou J; Liu Y; Shi S
Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):121-134. PubMed ID: 33054444
[TBL] [Abstract][Full Text] [Related]
4. Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters.
Ghose R; Omoluabi O; Gandhi A; Shah P; Strohacker K; Carpenter KC; McFarlin B; Guo T
Life Sci; 2011 Jul; 89(1-2):57-64. PubMed ID: 21620874
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of traditional Chinese medicine colquhounia root tablet on the pharmacokinetics of tacrolimus in rats.
Feng X; Shi Y; Ding Y; Zheng H
J Ethnopharmacol; 2022 Aug; 294():115358. PubMed ID: 35551976
[TBL] [Abstract][Full Text] [Related]
6. Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis.
Fritz A; Busch D; Lapczuk J; Ostrowski M; Drozdzik M; Oswald S
Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):245-255. PubMed ID: 30253071
[TBL] [Abstract][Full Text] [Related]
7. An antioxidant Trolox restores decreased oral absorption of cyclosporine A after liver ischemia-reperfusion through distinct mechanisms between CYP3A and P-glycoprotein in the small intestine.
Ikemura K; Inoue K; Mizutani H; Oka H; Iwamoto T; Okuda M
Eur J Pharmacol; 2012 Sep; 690(1-3):192-201. PubMed ID: 22749977
[TBL] [Abstract][Full Text] [Related]
8. Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats.
Hsiu SL; Hou YC; Wang YH; Tsao CW; Su SF; Chao PD
Life Sci; 2002 Dec; 72(3):227-35. PubMed ID: 12427482
[TBL] [Abstract][Full Text] [Related]
9. Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells.
Ikemura K; Urano K; Matsuda H; Mizutani H; Iwamoto T; Okuda M
J Pharmacol Exp Ther; 2009 Jan; 328(1):249-55. PubMed ID: 18842703
[TBL] [Abstract][Full Text] [Related]
10. Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats.
Balandraud-Pieri N; Queneau PE; Caroli-Bosc FX; Bertault-Pérès P; Montet AM; Durand A; Montet JC
Drug Metab Dispos; 1997 Aug; 25(8):912-6. PubMed ID: 9280397
[TBL] [Abstract][Full Text] [Related]
11. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
Shin SC; Choi JS; Li X
Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
[TBL] [Abstract][Full Text] [Related]
12. Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4.
Yu CP; Wu PP; Hou YC; Lin SP; Tsai SY; Chen CT; Chao PD
J Agric Food Chem; 2011 May; 59(9):4644-8. PubMed ID: 21466223
[TBL] [Abstract][Full Text] [Related]
13. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats.
Yang CY; Chao PD; Hou YC; Tsai SY; Wen KC; Hsiu SL
Food Chem Toxicol; 2006 Sep; 44(9):1572-8. PubMed ID: 16762474
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of docosahexaenoic acid as a bioavailability enhancer for CYP3A substrates: in vitro and in vivo evidence using cyclosporin in rats.
Hirunpanich V; Katagi J; Sethabouppha B; Sato H
Drug Metab Dispos; 2006 Feb; 34(2):305-10. PubMed ID: 16299163
[TBL] [Abstract][Full Text] [Related]
15. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
Li X; Choi JS
Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
[TBL] [Abstract][Full Text] [Related]
16. Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury.
Ibarra A; Guízar-Sahagún G; Correa D; Kretschmer R; Grijalva I; Flores-Murrieta FJ; Castañeda-Hernández G; Odor A; López RM; Franco-Bourland R; Espitia AL; Salgado-Ceballos H; Madrazo I
J Neurotrauma; 1996 May; 13(5):267-72. PubMed ID: 8797176
[TBL] [Abstract][Full Text] [Related]
17. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
[TBL] [Abstract][Full Text] [Related]
18. The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers.
Xin HW; Wu XC; Li Q; Yu AR; Zhong MY; Liu YY
Methods Find Exp Clin Pharmacol; 2006; 28(1):25-9. PubMed ID: 16541194
[TBL] [Abstract][Full Text] [Related]
19. Systemic exposure of Paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity.
Pingili RB; Pawar AK; Challa SR
Drug Dev Ind Pharm; 2015; 41(11):1793-800. PubMed ID: 25678313
[TBL] [Abstract][Full Text] [Related]
20. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
Shi S; Li Y
Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
